$CCCC
C4 Therapeutics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
C4 Therapeutics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CCCC down today? It is at $2.46 (-0.61%), and our scanner flagged it 161 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CCCC spikes, and full due diligence on CCCC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CCCC 161 times in the last 30 days. Create a free account to track $CCCC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CCCC from our scanner (live price and day move above). Our scanner has fired 11 unusual-volume and momentum alerts on CCCC today, peaking at 129.8x its normal volume.
Likely catalystC4 Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →We could not reach SEC EDGAR, so the dilution check did not run. This is not a clean result - verify on EDGAR before trading.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Adams Kendra Officer | Sold (automatic/other) | -45K 0.03% of company | sold 12% | 337K | $122K at $2.71 | Nov 12, 26 |
Grogan Donna Roy Director | Acquired (grant/award) | +5K | added 6.2% | 79K | $15K at $3.14 | Oct 1, 26 |
Anderson Kenneth Carl Director | Acquired (grant/award) | +4K | added 5.1% | 76K | $11K at $3.14 | Oct 1, 26 |
Adams Kendra Officer | Sold (automatic/other) | -3K | sold 0.7% | 382K | $9K at $3.39 | Sep 18, 26 |
Adams Kendra Officer | Other | 6K | added 1.6% | 385K | n/a | Sep 18, 26 |
Reyno Leonard Officer | Sold (automatic/other) | -7K | sold 1.9% | 372K | $30K at $4.06 | Jul 10, 26 |
Reyno Leonard Officer | Other | 15K 0.01% of company | added 4.2% | 380K | n/a | Jul 10, 26 |
Anderson Kenneth Carl Director | Acquired (grant/award) | +3K | added 3.8% | 72K | $12K at $4.34 | Jul 1, 26 |
Grogan Donna Roy Director | Acquired (grant/award) | +3K | added 4.7% | 75K | $14K at $4.34 | Jul 1, 26 |
Anderson Kenneth Carl Director | Other | 1K | added 1.6% | 69K | $2K at $2.11 | Jun 1, 26 |
Grogan Donna Roy Director | Acquired (grant/award) | +5K | added 8.1% | 72K | $14K at $2.70 | Apr 1, 26 |
Anderson Kenneth Carl Director | Acquired (grant/award) | +4K | added 6.7% | 68K | $11K at $2.70 | Apr 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CCCC from our scanner (live price and day move above). Our scanner has fired 11 unusual-volume and momentum alerts on CCCC today, peaking at 129.8x its normal volume.
CCCC last traded at $2.46, down 0.61% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CCCC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CCCC 161 times in the last 30 days.
CCCC (C4 Therapeutics, Inc.) trades on XNAS, with a market cap of about $325M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CCCC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CCCC discussion
Sign in to ask a question or join the discussion.